Cargando…
Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
We conducted this study to determine the effect of metformin use on the risk of new-onset chronic urticaria in patients with type 2 diabetes (T2D). In total, 24,987 pairs of metformin users and nonusers were identified with propensity score-matching from Taiwan’s National Health Insurance Research D...
Autores principales: | Yen, Fu-Shun, Hsu, Chih-Cheng, Hu, Kai-Chieh, Hung, Yu-Tung, Hsu, Chung Y., Wei, James Cheng-Chung, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517871/ https://www.ncbi.nlm.nih.gov/pubmed/36078769 http://dx.doi.org/10.3390/ijerph191711045 |
Ejemplares similares
-
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2020) -
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design
por: Yen, Fu-Shun, et al.
Publicado: (2018) -
Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)